Optics Letters, ISSN 0146-9592, 11/2015, Volume 40, Issue 21, pp. 4987 - 4990
This Letter presents the first quantitative assessment of the recently proposed metastable electronic state approach (MESA) for calculation of the nonlinear...
MULTIPHOTON | OPTICS | IONIZATION | FIELD | MOLECULES | PULSES | Electron states | Mesas | Computer simulation | Ionization | Nonlinearity | Mathematical models | Assessments | Nonlinear optics
MULTIPHOTON | OPTICS | IONIZATION | FIELD | MOLECULES | PULSES | Electron states | Mesas | Computer simulation | Ionization | Nonlinearity | Mathematical models | Assessments | Nonlinear optics
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2015, Volume 36, Issue 9, pp. 2587 - 2596
Abstract Decreased levels of alpha-synuclein (aSyn) in cerebrospinal fluid (CSF) in Parkinson's disease and related synucleinopathies have been reported,...
Neurology | Internal Medicine | Validation | Biomarker | Cerebrospinal fluid | Alpha-synuclein | ELISA | DEMENTIA | QUANTIFICATION | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | BIOMARKERS | RECOMMENDATIONS | ELEVATED LEVELS | CSF | DISCRIMINATE | LEWY BODIES | ALZHEIMERS | PARKINSONS-DISEASE | Reproducibility of Results | alpha-Synuclein - cerebrospinal fluid | Enzyme-Linked Immunosorbent Assay | United States | Europe | Humans | Parkinson Disease - cerebrospinal fluid | Female | Male | International Cooperation | Biomarkers - cerebrospinal fluid | Neurodegenerative Diseases - cerebrospinal fluid | Neurosciences | ALZHEIMERS-DISEASE | Geriatrics & Gerontology | Geriatrik | Neurovetenskaper | Geriatrics
Neurology | Internal Medicine | Validation | Biomarker | Cerebrospinal fluid | Alpha-synuclein | ELISA | DEMENTIA | QUANTIFICATION | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | BIOMARKERS | RECOMMENDATIONS | ELEVATED LEVELS | CSF | DISCRIMINATE | LEWY BODIES | ALZHEIMERS | PARKINSONS-DISEASE | Reproducibility of Results | alpha-Synuclein - cerebrospinal fluid | Enzyme-Linked Immunosorbent Assay | United States | Europe | Humans | Parkinson Disease - cerebrospinal fluid | Female | Male | International Cooperation | Biomarkers - cerebrospinal fluid | Neurodegenerative Diseases - cerebrospinal fluid | Neurosciences | ALZHEIMERS-DISEASE | Geriatrics & Gerontology | Geriatrik | Neurovetenskaper | Geriatrics
Journal Article
Growth Hormone and IGF Research, ISSN 1096-6374, 2014, Volume 24, pp. S28 - S28
Journal Article
Journal of Mathematical Physics, ISSN 0022-2488, 03/2016, Volume 57, Issue 3, p. 32105
Completeness of the system of Stark resonant states is investigated for a one-dimensional quantum particle with the Dirac-delta potential exposed to an...
PHYSICS, MATHEMATICAL | Convergence | QUANTUM SYSTEMS | CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSICS | APPROXIMATIONS | CONVERGENCE | ONE-DIMENSIONAL CALCULATIONS | DELTA FUNCTION | WAVE FUNCTIONS
PHYSICS, MATHEMATICAL | Convergence | QUANTUM SYSTEMS | CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSICS | APPROXIMATIONS | CONVERGENCE | ONE-DIMENSIONAL CALCULATIONS | DELTA FUNCTION | WAVE FUNCTIONS
Journal Article
5.
Full Text
Fire increases the risk of higher soil N2O emissions from Mediterranean Macchia ecosystems
Soil Biology and Biochemistry, ISSN 0038-0717, 03/2015, Volume 82, pp. 44 - 51
Intensification of droughts under climate change is projected to increase fire frequency in the Mediterranean region. Fires cause direct emission of greenhouse...
Mediterranean Macchia | Denitrification | N cycling | Fire effects | Nitrous oxide | Nitrification | CARBON | CH4 | NITROUS-OXIDE | SOIL SCIENCE | BIOMASS | WOODLAND | FLUXES | NET NITRIFICATION | TROPICAL SAVANNA
Mediterranean Macchia | Denitrification | N cycling | Fire effects | Nitrous oxide | Nitrification | CARBON | CH4 | NITROUS-OXIDE | SOIL SCIENCE | BIOMASS | WOODLAND | FLUXES | NET NITRIFICATION | TROPICAL SAVANNA
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2016, Volume 52, Issue 1, pp. 51 - 64
BACKGROUND: Assay-vendor independent quality control (QC) samples for neurochemical dementia diagnostics (NDD) biomarkers are so far commercially unavailable....
quality control | biomarkers | cerebrospinal fluid | laboratory diagnostics | amyloid-β | tau | Alzheimer's disease | ALZHEIMERS-DISEASE | STABILITY | QUANTIFICATION | MILD COGNITIVE IMPAIRMENT | NEUROSCIENCES | amyloid-beta | CEREBROSPINAL-FLUID BIOMARKERS | CSF | CLINICAL-PRACTICE | ASSOCIATION | PROGRAM | Serum Albumin, Bovine - analysis | Tissue Preservation - methods | Peptide Fragments - cerebrospinal fluid | Humans | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Amyloid beta-Peptides - blood | tau Proteins - blood | Reference Standards | Animals | Time Factors | Cattle | Peptide Fragments - blood | Amyloid beta-Peptides - cerebrospinal fluid | Dementia - cerebrospinal fluid | Anti-Bacterial Agents - pharmacology | Dementia - blood | Biomarkers - cerebrospinal fluid | Sodium Azide - pharmacology | Clinical Chemistry Tests - standards | Quality Control | Life Sciences | Neurosciences | Neurovetenskaper
quality control | biomarkers | cerebrospinal fluid | laboratory diagnostics | amyloid-β | tau | Alzheimer's disease | ALZHEIMERS-DISEASE | STABILITY | QUANTIFICATION | MILD COGNITIVE IMPAIRMENT | NEUROSCIENCES | amyloid-beta | CEREBROSPINAL-FLUID BIOMARKERS | CSF | CLINICAL-PRACTICE | ASSOCIATION | PROGRAM | Serum Albumin, Bovine - analysis | Tissue Preservation - methods | Peptide Fragments - cerebrospinal fluid | Humans | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Amyloid beta-Peptides - blood | tau Proteins - blood | Reference Standards | Animals | Time Factors | Cattle | Peptide Fragments - blood | Amyloid beta-Peptides - cerebrospinal fluid | Dementia - cerebrospinal fluid | Anti-Bacterial Agents - pharmacology | Dementia - blood | Biomarkers - cerebrospinal fluid | Sodium Azide - pharmacology | Clinical Chemistry Tests - standards | Quality Control | Life Sciences | Neurosciences | Neurovetenskaper
Journal Article
Urology, ISSN 0090-4295, 2013, Volume 81, Issue 1, pp. 143 - 149
Objective To retrospectively analyze the effects of treatment duration on outcomes of everolimus treatment of patients in the RAD001 Expanded-Access Clinical...
Urology | SUNITINIB | UROLOGY & NEPHROLOGY | EFFICACY | SORAFENIB | CARCINOMA | GUIDELINES | Dyspnea - chemically induced | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Humans | Middle Aged | Anemia - chemically induced | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Disease Progression | Hyperglycemia - chemically induced | Time Factors | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Carcinoma, Renal Cell - secondary | Stomatitis - chemically induced | Female | Kidney Neoplasms - pathology | Aged | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Everolimus | Sirolimus - adverse effects | Medical colleges | Care and treatment | Safety and security measures | Stem cells | Transplantation | Angiogenesis inhibitors | Cancer | Index Medicus
Urology | SUNITINIB | UROLOGY & NEPHROLOGY | EFFICACY | SORAFENIB | CARCINOMA | GUIDELINES | Dyspnea - chemically induced | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Humans | Middle Aged | Anemia - chemically induced | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Disease Progression | Hyperglycemia - chemically induced | Time Factors | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Carcinoma, Renal Cell - secondary | Stomatitis - chemically induced | Female | Kidney Neoplasms - pathology | Aged | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Everolimus | Sirolimus - adverse effects | Medical colleges | Care and treatment | Safety and security measures | Stem cells | Transplantation | Angiogenesis inhibitors | Cancer | Index Medicus
Journal Article
British Journal of Surgery, ISSN 0007-1323, 01/2015, Volume 102, Issue 1, pp. 45 - 56
Background Breast reconstruction aims to improve health‐related quality of life after mastectomy. However, evidence guiding patients and surgeons in shared...
SURGERY | DESIGN | MODULE | EUROPEAN ORGANIZATION | REPORTED OUTCOME MEASURES | QUALITY-OF-LIFE | CANCER | RADIATION | CONDUCT | PROTECT | Attitude of Health Personnel | Breast Neoplasms - surgery | Humans | Mastectomy - methods | Patient Care Team | United Kingdom | Mastectomy - psychology | Feasibility Studies | Patient Satisfaction | Patient Selection | Mammaplasty - psychology | Breast Neoplasms - psychology | Mammaplasty - methods | Quality of Life | Female | Surveys and Questionnaires | Patient Preference - psychology | Medical personnel | Mammaplasty
SURGERY | DESIGN | MODULE | EUROPEAN ORGANIZATION | REPORTED OUTCOME MEASURES | QUALITY-OF-LIFE | CANCER | RADIATION | CONDUCT | PROTECT | Attitude of Health Personnel | Breast Neoplasms - surgery | Humans | Mastectomy - methods | Patient Care Team | United Kingdom | Mastectomy - psychology | Feasibility Studies | Patient Satisfaction | Patient Selection | Mammaplasty - psychology | Breast Neoplasms - psychology | Mammaplasty - methods | Quality of Life | Female | Surveys and Questionnaires | Patient Preference - psychology | Medical personnel | Mammaplasty
Journal Article
Thorax, ISSN 0040-6376, 04/2004, Volume 59, Issue 4, pp. 279 - 285
Background: A description is given of a major outbreak of isoniazid monoresistant tuberculosis (TB) chiefly in north London, including prisons. The earliest...
MYCOBACTERIUM-TUBERCULOSIS | TRANSMISSION | UNITED-KINGDOM | THERAPY | PRISONS | RECOMMENDATIONS | RESPIRATORY SYSTEM | STRAIN | Tuberculosis, Multidrug-Resistant - ethnology | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Tuberculosis, Multidrug-Resistant - epidemiology | Contact Tracing | Polymorphism, Restriction Fragment Length | Disease Outbreaks | Adolescent | Adult | Female | Isoniazid - therapeutic use | Aged | London - epidemiology | Child | Antitubercular Agents - therapeutic use | Prisoners | Drug resistance in microorganisms | Development and progression | Tuberculosis | Research | Isoniazid | Epidemics | Enzymes | Statistical analysis | Disease | Colleges & universities | Epidemiology | Data bases | Prisons | Hospitals | Deoxyribonucleic acid--DNA | Community | Methods
MYCOBACTERIUM-TUBERCULOSIS | TRANSMISSION | UNITED-KINGDOM | THERAPY | PRISONS | RECOMMENDATIONS | RESPIRATORY SYSTEM | STRAIN | Tuberculosis, Multidrug-Resistant - ethnology | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Tuberculosis, Multidrug-Resistant - epidemiology | Contact Tracing | Polymorphism, Restriction Fragment Length | Disease Outbreaks | Adolescent | Adult | Female | Isoniazid - therapeutic use | Aged | London - epidemiology | Child | Antitubercular Agents - therapeutic use | Prisoners | Drug resistance in microorganisms | Development and progression | Tuberculosis | Research | Isoniazid | Epidemics | Enzymes | Statistical analysis | Disease | Colleges & universities | Epidemiology | Data bases | Prisons | Hospitals | Deoxyribonucleic acid--DNA | Community | Methods
Journal Article
Biopreservation and Biobanking, ISSN 1947-5535, 06/2015, Volume 13, Issue 3, pp. A-1 - A-59
Journal Article
Obstetric Anesthesia Digest, ISSN 0275-665X, 09/2014, Volume 34, Issue 3, pp. 153 - 154
(Lancet. 2013;381(9879):1747–1755)
Journal Article
Indian Heart Journal, ISSN 0019-4832, 01/2009, Volume 61, Issue 1, pp. 14 - 23
Rheumatic Heart Disease (RHD) is well known to be an active inflammatory process which develops progressive calcification and leaflet thickening over time. The...
Valvular heart disease | Clinical trials | Lipids | Pathophysiology | Aortic Valve Stenosis - prevention & control | Animals | Aortic Valve Stenosis - epidemiology | Mitral Valve Stenosis - prevention & control | Comorbidity | Mitral Valve Stenosis - epidemiology | Humans | Risk Factors | Rheumatic Heart Disease - prevention & control | Rheumatic Heart Disease - epidemiology | Causality
Valvular heart disease | Clinical trials | Lipids | Pathophysiology | Aortic Valve Stenosis - prevention & control | Animals | Aortic Valve Stenosis - epidemiology | Mitral Valve Stenosis - prevention & control | Comorbidity | Mitral Valve Stenosis - epidemiology | Humans | Risk Factors | Rheumatic Heart Disease - prevention & control | Rheumatic Heart Disease - epidemiology | Causality
Journal Article
Thorax, ISSN 0040-6376, 12/2004, Volume 59, Issue 12, pp. 1098 - 1099
[...]it may develop in patients with proven compliance but in whom perfusion is inadequate; and, secondly, it may be the result of poor penetration by the...
DRUG-RESISTANCE | RESPIRATORY SYSTEM | TUBERCULOSIS | CHEMOTHERAPY | Treatment Refusal | Isoniazid - therapeutic use | Humans | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Tuberculosis | Compliance | Drug resistance | Patients | Letter to the Editor
DRUG-RESISTANCE | RESPIRATORY SYSTEM | TUBERCULOSIS | CHEMOTHERAPY | Treatment Refusal | Isoniazid - therapeutic use | Humans | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Tuberculosis | Compliance | Drug resistance | Patients | Letter to the Editor
Journal Article
Thorax, ISSN 0040-6376, 2004, Volume 59, Issue 12, pp. 1098 - 1099
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/1999, Volume 81, Issue 8, pp. 1280 - 1284
Assessment of the chemosensitivity of dendritic cells (DC) may allow more rational development of combined chemotherapy and immunotherapy protocols. Human...
Human | Dendritic cell | Chemotherapy | MTS | Immunotherapy | PHARMACOKINETICS | ONCOLOGY | immunotherapy | HUMAN BLOOD | GENERATION | human | chemotherapy | CANCER | EXPRESSION | dendritic cell | Reproducibility of Results | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Cells, Cultured | Dendritic Cells - drug effects | Antineoplastic Agents - pharmacology | Dendritic Cells - metabolism | Lymphocyte Culture Test, Mixed | Regular
Human | Dendritic cell | Chemotherapy | MTS | Immunotherapy | PHARMACOKINETICS | ONCOLOGY | immunotherapy | HUMAN BLOOD | GENERATION | human | chemotherapy | CANCER | EXPRESSION | dendritic cell | Reproducibility of Results | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Cells, Cultured | Dendritic Cells - drug effects | Antineoplastic Agents - pharmacology | Dendritic Cells - metabolism | Lymphocyte Culture Test, Mixed | Regular
Journal Article
09/2004, 7
Patent
Journal of Materials Science, ISSN 0022-2461, 09/1967, Volume 2, Issue 5, pp. 500 - 502
Journal Article
S.A.E. PAPER 750805, 1975, p. 1975
Journal Article
Surface Science, ISSN 0039-6028, 1967, Volume 8, Issue 4, pp. 473 - 477
Journal Article
Carbon, ISSN 0008-6223, 1967, Volume 5, Issue 6, pp. 587,IN23,589 - 588,IN24,589
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.